Synokem Pharmaceuticals Limited
Synokem Pharmaceuticals Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1988, the company has established itself as a leader in the development and manufacturing of high-quality generic and specialty pharmaceuticals. With a diverse portfolio that includes formulations in therapeutic areas such as cardiology, neurology, and anti-infectives, Synokem is recognised for its commitment to innovation and quality. The company’s state-of-the-art manufacturing facilities adhere to stringent international standards, ensuring the delivery of safe and effective products. Synokem Pharmaceuticals has achieved significant milestones, including regulatory approvals from major global health authorities, solidifying its market position. With a focus on research and development, Synokem continues to expand its reach, contributing to improved healthcare outcomes worldwide.
DitchCarbon Score
How does Synokem Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Synokem Pharmaceuticals Limited's score of 4 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Synokem Pharmaceuticals Limited's reported carbon emissions
Synokem Pharmaceuticals Limited, headquartered in India, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is unclear how the company is addressing its carbon footprint or what commitments it has made towards climate action. In the pharmaceutical industry, companies are increasingly focusing on sustainability and reducing greenhouse gas emissions, often through initiatives aimed at improving energy efficiency and transitioning to renewable energy sources. However, without specific data or commitments from Synokem Pharmaceuticals, it is difficult to assess their current climate impact or future goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Synokem Pharmaceuticals Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
